The first clinical trial in the US to test an experimental COVID-19 treatment highlights the central role that master protocol trials can play in coordinating R&D in the face of an emerging threat.
National Institute of Allergy and Infectious Diseases (NIAID)’s COVID-19 adaptive treatment trial started on 21 February 2020 in Omaha, Nebraska,...







